BridgeMD
New treatment option for Solid Tumor
Official title Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
ClinicalTrials.gov ID: NCT07151040
What this study is testing
What is TH9619?
TH9619 is an investigational medicine, being studied as a potential treatment for solid tumor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a first in human, multi-center, open-label, dosage escalation study to determine the recommended dose range of TH9619 in subjects with advanced cancer.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Must have given written informed consent
- Histopathologically confirmed advanced cancer (colorectal cancer, head and neck squamous cell cancer, non-small cell lung cancer and gastric cancer...
- Prior treatment with at least one line of cytotoxic systemic therapy for metastatic/unresectable cancer
- Adult patients (≥18 years of age)
- Must be willing to comply with study procedures
You likely can't join if
- History or presence of any clinically significant disorders as judged by the Investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Villejuif, France
- Barcelona, Spain
- Madrid, Spain
- Newcastle upon Tyne, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Villejuif, France; Barcelona, Spain; Madrid, Spain; Newcastle upon Tyne, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.